Human Amniotic-Derived Mesenchymal Stem Cell Therapy

human amniotic-derived mesenchymal stem cells · The First Affiliated Hospital with Nanjing Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human Amniotic-Derived Mesenchymal Stem Cell Therapy, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis [EARLY_Phase 1]

See pricing